Xu R - Search Results

1

Antiangiogenic therapy enhances the efficacy of transcatheter arterial embolization for hepatocellular carcinomas.

Jiang H, Meng Q, Tan H, Pan S, Sun B, Xu R, Sun X. Jiang H, et al. Among authors: xu r. Int J Cancer. 2007 Jul 15;121(2):416-24. doi: 10.1002/ijc.22655. Int J Cancer. 2007. PMID: 17330237

2

Antisense hypoxia-inducible factor-1alpha augments transcatheter arterial embolization in the treatment of hepatocellular carcinomas in rats.

Sun X, Jiang H, Jiang X, Tan H, Meng Q, Sun B, Xu R, Krissansen GW. Sun X, et al. Among authors: xu r. Hum Gene Ther. 2009 Apr;20(4):314-24. doi: 10.1089/hum.2008.164. Hum Gene Ther. 2009. PMID: 19327024

3

Combining kallistatin gene therapy and meloxicam to treat hepatocellular carcinoma in mice.

Jiang X, Li H, Qiao H, Jiang H, Xu R, Sun X. Jiang X, et al. Among authors: xu r. Cancer Sci. 2009 Nov;100(11):2226-33. doi: 10.1111/j.1349-7006.2009.01306.x. Epub 2009 Aug 4. Cancer Sci. 2009. PMID: 19709125 Free PMC article.

4

Anti-angiogenic therapy subsequent to adeno-associated-virus-mediated immunotherapy eradicates lymphomas that disseminate to the liver.

Sun X, Krissansen GW, Fung PW, Xu S, Shi J, Man K, Fan ST, Xu R. Sun X, et al. Among authors: xu r, xu s. Int J Cancer. 2005 Feb 10;113(4):670-7. doi: 10.1002/ijc.20624. Int J Cancer. 2005. PMID: 15472906

5

Intramuscular delivery of antiangiogenic genes suppresses secondary metastases after removal of primary tumors.

Sun X, Qiao H, Jiang H, Zhi X, Liu F, Wang J, Liu M, Dong D, Kanwar JR, Xu R, Krissansen GW. Sun X, et al. Among authors: xu r. Cancer Gene Ther. 2005 Jan;12(1):35-45. doi: 10.1038/sj.cgt.7700766. Cancer Gene Ther. 2005. PMID: 15486558

6

Adeno-associated virus-mediated expression of kallistatin suppresses local and remote hepatocellular carcinomas.

Tse LY, Sun X, Jiang H, Dong X, Fung PW, Farzaneh F, Xu R. Tse LY, et al. Among authors: xu r. J Gene Med. 2008 May;10(5):508-17. doi: 10.1002/jgm.1180. J Gene Med. 2008. PMID: 18338836

7

Recombinant adeno-associated virus-mediated TRAIL gene therapy suppresses liver metastatic tumors.

Ma H, Liu Y, Liu S, Kung HF, Sun X, Zheng D, Xu R. Ma H, et al. Among authors: xu r. Int J Cancer. 2005 Aug 20;116(2):314-21. doi: 10.1002/ijc.20982. Int J Cancer. 2005. PMID: 15800912

8

[Construction and activity of recombinant adeno-associated virus expressing vasostatin].

Diao Y, Ma J, Li X, Sun X, Xu R. Diao Y, et al. Among authors: xu r. Sheng Wu Gong Cheng Xue Bao. 2008 Nov;24(11):1949-54. Sheng Wu Gong Cheng Xue Bao. 2008. PMID: 19256344 Chinese.

9

Overexpression of von Hippel-Lindau tumor suppressor protein and antisense HIF-1alpha eradicates gliomas.

Sun X, Liu M, Wei Y, Liu F, Zhi X, Xu R, Krissansen GW. Sun X, et al. Among authors: xu r. Cancer Gene Ther. 2006 Apr;13(4):428-35. doi: 10.1038/sj.cgt.7700907. Cancer Gene Ther. 2006. PMID: 16211089

10

Long-term expression of angiostatin suppresses metastatic liver cancer in mice.

Xu R, Sun X, Tse LY, Li H, Chan PC, Xu S, Xiao W, Kung HF, Krissansen GW, Fan ST. Xu R, et al. Among authors: xu s. Hepatology. 2003 Jun;37(6):1451-60. doi: 10.1053/jhep.2003.50244. Hepatology. 2003. PMID: 12774025

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,498 results

Search Page

Filters